HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Di Paolo Selected Research

BAL9611

6/2001Inhibition of protein farnesylation enhances the chemotherapeutic efficacy of the novel geranylgeranyltransferase inhibitor BAL9611 in human colon cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Di Paolo Research Topics

Disease

7Neoplasms (Cancer)
09/2013 - 06/2001
6Colorectal Neoplasms (Colorectal Cancer)
04/2011 - 08/2001
3Colonic Neoplasms (Colon Cancer)
05/2008 - 02/2000
2Breast Neoplasms (Breast Cancer)
09/2013 - 12/2005
2Diarrhea
04/2009 - 12/2002
1Paratuberculosis (Johne's Disease)
07/2018
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2014
1Reinfection
01/2013
1Thrombosis (Thrombus)
04/2011
1Rhabdomyolysis
12/2010
1Infections
08/2009
1Persistent Infection
08/2009
1Osteomyelitis
08/2009
1Body Weight (Weight, Body)
03/2009
1Autoimmune Diseases (Autoimmune Disease)
03/2009
1Serotonin Syndrome (Syndrome, Serotonin)
07/2008
1Nephrogenic Diabetes Insipidus
05/2005
1Renal Insufficiency (Renal Failure)
05/2005
1Kaposi Sarcoma (Kaposi's Sarcoma)
11/2004
1Ovarian Neoplasms (Ovarian Cancer)
11/2004
1Stomatitis
12/2002
1Vomiting
12/2002
1Dermatitis
12/2002
1Neutropenia
12/2002
1Bradycardia
12/2001
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2000

Drug/Important Bio-Agent (IBA)

4Irinotecan (Camptosar)FDA LinkGeneric
04/2009 - 08/2001
3Pharmaceutical PreparationsIBA
04/2011 - 08/2000
3Fluorouracil (Carac)FDA LinkGeneric
12/2002 - 08/2001
2manumycinIBA
06/2001 - 02/2000
2TransferasesIBA
06/2001 - 02/2000
1BiofuelsIBA
07/2018
1ManureIBA
07/2018
1Organic Cation Transporter 1IBA
08/2014
1Imatinib Mesylate (Gleevec)FDA Link
08/2014
1VaccinesIBA
01/2013
1Bevacizumab (Avastin)FDA Link
04/2011
1Genetic Markers (Genetic Marker)IBA
04/2011
1Heparin (Liquaemin)FDA LinkGeneric
04/2011
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
04/2011
1Tissue Plasminogen Activator (Alteplase)FDA Link
04/2011
1DaptomycinFDA Link
12/2010
1TeicoplaninIBA
08/2009
1GlycopeptidesIBA
08/2009
1Anti-Bacterial Agents (Antibiotics)IBA
08/2009
1Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2009
1Capecitabine (Xeloda)FDA Link
04/2009
1thiopurine methyltransferase (thiopurine S-methyltransferase)IBA
03/2009
15-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
07/2008
1Thrombospondin 1IBA
05/2008
1Semaxinib (SU5416)IBA
05/2008
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2008
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
12/2005
1idarubicinolIBA
12/2005
1LithiumIBA
05/2005
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2004
1Cytotoxins (Cytolysins)IBA
11/2004
1PhysostigmineIBA
12/2001
1Leucovorin (Folinic Acid)FDA Link
09/2001
1Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
09/2001
1EnzymesIBA
06/2001
1BAL9611IBA
06/2001
1Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric
08/2000
16-thioguanylic acidIBA
08/2000
1NucleotidesIBA
08/2000
1Phosphotransferases (Kinase)IBA
02/2000
1Proteins (Proteins, Gene)FDA Link
02/2000

Therapy/Procedure

4Drug Therapy (Chemotherapy)
05/2008 - 08/2001
3Therapeutics
04/2011 - 12/2002
1Neoadjuvant Therapy
09/2013
1Segmental Mastectomy (Lumpectomy)
09/2013
1Thrombolytic Therapy
04/2011
1Debridement
08/2009
1Duration of Therapy
03/2009